Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Baay

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|August 25, 2020
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issuesMarc Baay, Pieter Neels
Sexual Health|August 6, 2009
People seeking health information about human papillomavirus via the internet have a very high level of anxietyVeronique Verhoeven, Marc Baay, Pieter Baay
Vaccine|June 11, 2018
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adultsMarc Baay, Kaatje Bollaerts, Thomas Verstraeten
Vaccine|January 8, 2016
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among childrenJorgen Stassijns, Kaatje Bollaerts, Marc Baay, et al.
Human Vaccines & Immunotherapeutics|April 26, 2017
Background rates of disease in Latin American children from a rotavirus vaccine studyMarc Baay, Kaatje Bollaerts, Claudio Struchiner, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 8, 2020
Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting reportAndrew J Pollard, Robert Sauerwein, Marc Baay, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 12, 2020
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019Isabelle Bekeredjian-Ding, Wim Van Molle, Marc Baay, et al.
Clinical & Developmental Immunology|December 14, 2011
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapyMarc Baay, Anja Brouwer, Patrick Pauwels, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|May 28, 2011
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSIVanessa Deschoolmeester, Marc Baay, Filip Lardon, et al.
The Oncologist|June 30, 2010
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapyVanessa Deschoolmeester, Marc Baay, Pol Specenier, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Biologicals : Journal of the International Association of Biological Standardization|August 25, 2020
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issuesMarc Baay, Pieter Neels
Sexual Health|August 6, 2009
People seeking health information about human papillomavirus via the internet have a very high level of anxietyVeronique Verhoeven, Marc Baay, Pieter Baay
Vaccine|June 11, 2018
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among older adultsMarc Baay, Kaatje Bollaerts, Thomas Verstraeten
Vaccine|January 8, 2016
A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among childrenJorgen Stassijns, Kaatje Bollaerts, Marc Baay, et al.
Human Vaccines & Immunotherapeutics|April 26, 2017
Background rates of disease in Latin American children from a rotavirus vaccine studyMarc Baay, Kaatje Bollaerts, Claudio Struchiner, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 8, 2020
Third human challenge trial conference, Oxford, United Kingdom, February 6-7, 2020, a meeting reportAndrew J Pollard, Robert Sauerwein, Marc Baay, et al.
Biologicals : Journal of the International Association of Biological Standardization|May 12, 2020
Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019Isabelle Bekeredjian-Ding, Wim Van Molle, Marc Baay, et al.
Clinical & Developmental Immunology|December 14, 2011
Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapyMarc Baay, Anja Brouwer, Patrick Pauwels, et al.
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|May 28, 2011
Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSIVanessa Deschoolmeester, Marc Baay, Filip Lardon, et al.
The Oncologist|June 30, 2010
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapyVanessa Deschoolmeester, Marc Baay, Pol Specenier, et al.
Pageof 6